Novel Small Molecule Drugs for the Treatment of Triple-Class Refractory Myeloma
September 29th 2021Robert Z. Orlowski, MD, PhD, director of the Myeloma Section at the University of Texas MD Anderson Cancer Center, reviewed novel agents in the treatment of triple-class refractory myeloma during a session at the 2021 annual meeting of the Society of Hematologic Oncology (SOHO).
Read More
Apalutamide Demonstrates Strong PSA Response in Patients With Advanced Prostate Cancer
September 20th 2021Apalutamide (Erleada, Johnson & Johnson) demonstrated a strong prostate-specific antigen response and high adherence rates in patients with non-metastatic castration-resistant prostate cancer.
Read More
Clinical Trial Evaluating Vaccine Against Opioid Use Disorders Enrolls First Patients
September 17th 2021Funded by a grant from the National Institutes of Health, this trial is intended to test the safety and efficacy of a vaccine designed to selectively prevent the euphoric and toxic effects of oxycodone.
Read More
Study: Lung Function Unaffected After COVID-19 Infection in Young Adults
September 8th 2021The investigators said that even patients with asthma showed no statistically significant deterioration in lung function, although there was a trend toward slightly lower measurements for the amount of air they could exhale forcibly in 1 second.
Read More
Study Identifies New Risk Factors for Certain Bleeding Complications Following Myocardial Infarction
September 8th 2021Bleeding in the upper GI tract is among the most common bleeding complications following acute myocardial infarction, causing considerable suffering and increasing the risk of death.
Read More
Study: Vaccination Against COVID-19 Produces Antibodies in 90% of Patients Taking Immunosuppressants
September 1st 2021The investigators, from Washington University School of Medicine in St. Louis, note that the responses measured were one-third as strong as those mounted by healthy individuals.
Read More
Lisdexamfetamine Reduces Symptoms of Cognitive Sluggishness in Adult Patients With ADHD
August 31st 2021It is currently debated whether or not sluggish cognitive tempo—defined as a collection of symptoms that include persistent dreaminess, fatigue, and slow working speed—is part of ADHD or separate from it.
Read More
Pharmacy Fact: What is the Best City for Mental Health Care in the United States?
August 27th 2021Cities were ranked on a 50 point scale, weighing factors including therapy session rate by state, total prescription charges by state, their grade for mandatory treatment laws by state, criminalization of mental illness by state, number of residents per 1 mental health provider by county, poor mental health days by county, and overall community wellbeing.
Read More